We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Biomarkers in Atopic Dermatitis

    Atopic dermatitis (AD) is a chronic inflammatory skin condition. The pathogenesis involves genetic, environmental, and immunological factors as well...

    Florence Libon, Juliette Caron, Arjen F. Nikkels in Dermatology and Therapy
    Article Open access 14 June 2024
  2. Blood-Based Biomarkers for Managing Workload in Athletes: Perspectives for Research on Emerging Biomarkers

    At present, various blood-based biomarkers have found their applications in the field of sports medicine. This current opinion addresses biomarkers...

    Nils Haller, Thomas Reichel, ... Perikles Simon in Sports Medicine
    Article Open access 21 June 2023
  3. Tumor biomarkers for diagnosis, prognosis and targeted therapy

    Tumor biomarkers, the substances which are produced by tumors or the body’s responses to tumors during tumorigenesis and progression, have been...

    Yue Zhou, Lei Tao, ... Yinglan Zhao in Signal Transduction and Targeted Therapy
    Article Open access 20 May 2024
  4. Blood-Based Biomarkers for Managing Workload in Athletes: Considerations and Recommendations for Evidence-Based Use of Established Biomarkers

    Blood-based biomarkers can provide an objective individualized measure of training load, recovery, and health status in order to reduce injury risk...

    Nils Haller, Michael Behringer, ... Thomas Stöggl in Sports Medicine
    Article Open access 19 May 2023
  5. Circulating non-coding RNA biomarkers of endocrine tumours

    Circulating non-coding RNA (ncRNA) molecules are being investigated as biomarkers of malignancy, prognosis and follow-up in several neoplasms,...

    Henriett Butz, Attila Patócs, Peter Igaz in Nature Reviews Endocrinology
    Article 17 June 2024
  6. Biomarkers in osteoarthritis: current status and outlook — the FNIH Biomarkers Consortium PROGRESS OA study

    Currently, no disease-modifying therapies are approved for osteoarthritis (OA) use. One obstacle to trial success in this field has been our existing...

    David J. Hunter, Jamie E. Collins, ... Virginia B. Kraus in Skeletal Radiology
    Article Open access 24 January 2023
  7. Urinary Biomarkers of Detrusor Underactivity

    Purpose of Review

    Detrusor underactivity (DU) is a urodynamic diagnosis, often related with the multifactorial symptom complex designated as...

    João Oliveira, Gabriel Faria-Costa, ... Tiago Antunes-Lopes in Current Bladder Dysfunction Reports
    Article 29 January 2024
  8. Do hematological biomarkers predict surgical necrotizing enterocolitis?

    Necrotizing enterocolitis (NEC) is a devastating gastrointestinal emergency in preterm infants and the clinical presentation of NEC may vary with...

    Srinivasan Mani, Parvesh Mohan Garg, Mohan Pammi in Pediatric Research
    Article 31 January 2024
  9. Current and Future Biomarkers in Esophagogastric Adenocarcinoma

    Purpose

    Biomarker-based therapies have shown improved patient outcomes across various cancer types. The purpose of this review to summarize our...

    Ryan Sappenfield, Eric Mehlhaff, ... Nataliya V. Uboha in Journal of Gastrointestinal Cancer
    Article 27 January 2024
  10. Molecular biomarkers for vascular cognitive impairment and dementia

    As disease-specific interventions for dementia are being developed, the ability to identify the underlying pathology and dementia subtypes is...

    Satoshi Hosoki, Gurpreet K. Hansra, ... Perminder S. Sachdev in Nature Reviews Neurology
    Article 13 November 2023
  11. Serological Biomarkers of Chronic Migraine

    Purpose of Review

    Chronic migraine (CM) is a chronic form of migraine that differs from episodic migraine (EM) in terms of prevalence, comorbidities,...

    Soomi Cho, Min Kyung Chu in Current Pain and Headache Reports
    Article 10 August 2023
  12. Biomarkers of Hepatic Dysfunction and Cardiovascular Risk

    Purpose of Review

    The objective of this manuscript is to examine the current literature on non-alcoholic fatty liver disease (NAFLD) biomarkers and...

    Terence B. Lee Jr, Martin T. W. Kueh, ... Anurag Mehta in Current Cardiology Reports
    Article 16 November 2023
  13. Biomarkers for urinary tract infection: present and future perspectives

    A prompt diagnosis of urinary tract infection (UTI) is necessary to minimize its symptoms and limit sequelae. The current UTI screening by urine test...

    Tej K. Mattoo, John David Spencer in Pediatric Nephrology
    Article 14 March 2024
  14. Sex Differences in Circulating Biomarkers of Heart Failure

    Purpose of RevSiew

    Evidence is scaling up for sex differences in heart failure; however, clinical relevance of sex-specific differential thresholds...

    Roopa A. Rao, Anju Bhardwaj, ... Eman Hamad in Current Heart Failure Reports
    Article 07 December 2023
  15. Prostate cancer biomarkers: from early diagnosis to precision treatment

    Prostate cancer (PCa) is the second most prevalent cancer in men. In 2020, approximately 1,414,259 new cases were reported that accounted for...

    Versha Dahiya, Sanjana Hans, ... Gargi Bagchi in Clinical and Translational Oncology
    Article 14 May 2024
  16. Liquid biomarkers in glioma

    An ideal biomarker must meet several parameters to enable its successful adoption; however, the nature of glioma makes it challenging to discover...

    Sho Tamai, Toshiya Ichinose, Mitsutoshi Nakada in Brain Tumor Pathology
    Article 17 February 2023
  17. Identification and verification of inflammatory biomarkers for primary Sjögren’s syndrome

    Introduction

    Primary Sjögren’s syndrome (pSS) is an autoimmune disease characterized by inflammatory infiltration, and dysfunction of the salivary and...

    **aodan Liu, Haojie Wang, ... Zhihui Zhang in Clinical Rheumatology
    Article Open access 20 February 2024
  18. Diagnostic liquid biopsy biomarkers in renal cell cancer

    The clinical presentation of renal cell cancer (RCC) is shifting towards incidental and early detection, creating new challenges in RCC diagnosis....

    Richard C. Zieren, Patricia J. Zondervan, ... Adriaan D. Bins in Nature Reviews Urology
    Article 27 September 2023
  19. Novel Blood-Based Biomarkers for HCC

    Purpose of Review

    Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality. Early detection is crucial for improving patient survival....

    Suraj Pai, Neehar D. Parikh in Current Hepatology Reports
    Article 03 January 2024
  20. Lifestyle and demographic associations with 47 inflammatory and vascular stress biomarkers in 9876 blood donors

    Background

    The emerging use of biomarkers in research and tailored care introduces a need for information about the association between biomarkers and...

    Bertram Kjerulff, Joseph Dowsett, ... Christian Erikstrup in Communications Medicine
    Article Open access 16 March 2024
Did you find what you were looking for? Share feedback.